Mouse Genome Informatics
cn1
    Nr4a2tm2.1Tpe/Nr4a2tm2.1Tpe
Not Specified
Key:
phenotype observed in females WTSI Wellcome Trust Sanger Institute
phenotype observed in males Euro Europhenome
N normal phenotype
nervous system
N
• injection of adenovirus expressing cre do not alter brain morphology, expression of midbrain dopamine neuron markers, or microglia activation (J:157098)
• in the dorsolateral striatum and areas innervated by scattered ventral tegmental area of mice injected with an adenovirus expressing cre
• mice injected with an adenovirus expressing cre exhibit a progressive decrease in dopaminergic neurons compared with wild-type mice

behavior/neurological
• 3 to 4 months after injection with an adenovirus expressing cre, mice exhibit impaired performance in a stepping test compared with wild-type mice

homeostasis/metabolism
• in the dorsolateral striatum and areas innervated by scattered ventral tegmental area of mice injected with an adenovirus expressing cre


Mouse Genome Informatics
cn2
    Nr4a2tm2.1Tpe/Nr4a2tm2.1Tpe
Slc6a3tm1(cre)Lrsn/Slc6a3tm1(cre)Lrsn

involves: 129S1/Sv * 129X1/SvJ
Key:
phenotype observed in females WTSI Wellcome Trust Sanger Institute
phenotype observed in males Euro Europhenome
N normal phenotype
mortality/aging
• mice do not survive beyond 3 weeks
• however, leaving pups with mothers improves perinatal survival beyond 3 weeks

nervous system
• at P1, striatal dopamine levels are decreased to 14% of wild-type
• at P14, the ratio of homovanillic acid (HVA) to dopamine is increased indicating increased dopamine turnover compared to in wild-type mice
• at P60, striatal dopamine levels are almost completely lost unlike in wild-type mice
• at P60, dopamine levels are more severely decreased in the caudate putamen compared to in the nucleus accumbens
• expression of midbrain dopamine neuron markers is lost compared to in wild-type mice
• mice exhibit a rapid loss of substantia nigra pars compacta cell bodies with only scattered ventral tegmental area neurons remaining compared with wild-type mice

behavior/neurological
• at 4 and 14 months
• L-DOPA-treated mice exhibit hyperactivity unlike similarly treated wild-type mice
• L-DOPA-treated mice exhibit repetitive behaviors (including repetitive gnawing, excessive grooming, and self-injury) unlike similarly treated wild-type mice

homeostasis/metabolism
• at P1, striatal dopamine levels are decreased to 14% of wild-type
• at P14, the ratio of homovanillic acid (HVA) to dopamine is increased indicating increased dopamine turnover compared to in wild-type mice
• at P60, striatal dopamine levels are almost completely lost unlike in wild-type mice
• at P60, dopamine levels are more severely decreased in the caudate putamen compared to in the nucleus accumbens
• serotonin levels in the caudate putamen and nucleus accumbens are increased compared to in wild-type mice
• L-DOPA-treated mice exhibit hyperactivity and repetitive behaviors unlike similarly treated wild-type mice

growth/size
• at 2 months, mice left with their mothers after weaning are 40% smaller than wild-type mice